Author

Pablo Castañeda-Casado

GlaxoSmithKline (Spain)ORCID 0000-0002-0514-7306Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Garcia-Perez· 1 shared Adolfo García-Pérez· 1 shared Alain R. BaulardiD· 1 shared Amy Kristine BeiiD· 1 shared Ana Yepes· 1 shared Anasuya Chattopadhyay PaliD· 1 shared Anita SarafiD· 1 shared C. ReyiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Garcia-Perez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 27, 2026

DDU384: A new preclinical candidate for the treatment of Tuberculosis

Simon R. Green, Kirsteen I. Buchanan, Helena I. Boshoff…·Laura A. T. Cleghorn

This paper identifies DDU384, a new compound with potent in vivo efficacy against tuberculosis in murine models, showing potential to improve current treatment options.

DOI 10.64898/2026.10.26.760366

mouseexperimental assay

𝕏 PostBluesky

MicrobiologySciencePeer-reviewedSep 26, 2024

A Potent Kalihinol Analogue Disrupts Apicoplast Function and Vesicular Trafficking in P. falciparum Malaria.

Zeinab M Chahine, S. Abel, Thomas Hollin…·Karine G. Le Roch

This paper identifies MED6-189, a potent antimalarial compound that disrupts apicoplast function and vesicular trafficking in P. falciparum, showing efficacy against drug-resistant strains and demonstrating a unique mechanism of action.

18 citationstop 3%

humanexperimental assay

𝕏 PostBluesky